MARKET

ONVO

ONVO

Organovo Holding
NASDAQ
2.740
-0.100
-3.52%
Closed 19:58 03/26 EDT
OPEN
3.120
PREV CLOSE
2.840
HIGH
3.120
LOW
2.630
VOLUME
139.82K
TURNOVER
31.95K
52 WEEK HIGH
21.96
52 WEEK LOW
2.630
MARKET CAP
4.93M
P/E (TTM)
-3.1702
1D
5D
1M
3M
1Y
5Y
1D
Organovo Holdings Completes FXR Program Sale to Eli Lilly
TipRanks · 22h ago
ORGANOVO ANNOUNCES CLOSE OF THE SALE OF FXR PROGRAM TO ELI LILLY AND COMPANY
Reuters · 1d ago
Press Release: Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company
Dow Jones · 1d ago
Weekly Report: what happened at ONVO last week (0317-0321)?
Weekly Report · 3d ago
Organovo Has Received A Notice Of Allowance For A U.S. Patent Titled "Engineered Intestinal Tissue And Uses Thereof"
Benzinga · 5d ago
Organovo trading halted, news pending
TipRanks · 6d ago
Nasdaq Gains Over 1%; Williams-Sonoma Shares Plunge After Q4 Results
Benzinga · 03/19 14:20
Organovo announces reverse stock split; shares fall
Seeking Alpha · 03/19 12:14
More
About ONVO
Organovo Holdings, Inc. is a clinical-stage biotechnology company. The Company is developing drugs that are demonstrated to be effective in three-dimensional (3D) human tissues as candidates for drug development. It focuses on developing novel treatment approaches in inflammatory bowel disease (IBD). The Company has proprietary technology used to build 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. It uses its proprietary technology to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. Its Mosaic division to serve as a key source of certain primary human cells it utilizes in its research and development efforts. Its 3D human tissue platform is multifaceted. Its NovoGen Bioprinters can also dispense pure hydrogel formulations, provided the physical properties of the hydrogel are compatible with the dispensing parameters.

Webull offers Organovo Holdings Inc stock information, including NASDAQ: ONVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONVO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ONVO stock methods without spending real money on the virtual paper trading platform.